Yuanjing Xu is a highly experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Sr. Director at IQVIA. Xu has held significant leadership roles, including Executive Director at a biotech company and Senior Director at Syneos Health. Additional experience includes serving as Project Director at IQVIA and Senior Project Manager at Covance. Yuanjing Xu holds an extensive academic background, having earned a PhD and M.D. in Medicine, as well as a Master and Bachelor Degree in Medicine, all from Beijing University of Chinese Medicine, where studies were completed from 1993 to 2003.